Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 10, 2026 | Surest (UnitedHealthcare) | Veopoz (Pozelimab-Bbfg) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Vagus and External Trigeminal Nerve Stimulation | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Ustekinumab | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Upper Extremity Prosthetic Devices | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Uplizna (Inebilizumab-Cdon) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Umbilical Cord Blood Harvesting and Storage for Future Use | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Tzield (Teplizumab-Mzwv) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Trogarzo (Ibalizumab-Uiyk) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Tremfya (Guselkumab) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Transcranial Magnetic Stimulation for Treating Physical Health Conditions | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Transcatheter Procedures for Heart Valve Conditions | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Total Artificial Disc Replacement for the Spine | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Tocilizumab Injection for Intravenous Infusion | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Tezspire (Tezepelumab-Ekko) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Testosterone Replacement or Supplementation Therapy | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Tepezza (Teprotumumab-Trbw) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Synagis (Palivizumab) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Sympathetic Blockade | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Susvimo (Ranibizumab Injection) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Surgery of the Knee | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Surgery of the Wrist or Thumb | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Surgery of the Foot | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Surgery of the Elbow | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Surgery of the Ankle | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Surgery for the Prevention and Treatment of Lymphedema | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Subcutaneous Implantable Naltrexone Pellets | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Spinraza (Nusinersen) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Spinal Fusion and Decompression | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Spinal Fusion and Bone Healing Enhancement Products | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Spevigo (Spesolimab-Sbzo) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Somatostatin Analogs | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Sodium Hyaluronate | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Sleep Studies | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Skyrizi (Risankizumab-Rzaa) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Skin and Soft Tissue Substitutes | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Simponi Aria (Golimumab) Injection for Intravenous Infusion | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Sensory Integration Therapy and Auditory Integration Training | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Self-Administered Medications | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Scenesse (Afamelanotide) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Saphnelo (Anifrolumab-Fnia) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Sacroiliac Joint Interventions | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Sacral Nerve Stimulation for Urinary and Fecal Indications | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Ryplazim (Plasminogen, Human-Tvmh) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Roctavian (Valoctocogene Roxaparvovec-Rvox) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | RNA-Targeted Therapies (Amvuttra and Onpattro) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Rituximab (Riabni, Rituxan, Ruxience, & Truxima) | Criteria changed |
| May 10, 2026 | Surest (UnitedHealthcare) | Review at Launch for New to Market Medications | Criteria changed |